Even though we live in a continuously expanding diabetes tech age, we’re always excited when a product we love gets an upgrade. On December 8, 2022, Dexcom’s G7 CGM got the green light from the FDA. See what the next gen brings!
read more →
If you’re not utilizing your trend arrows and reacting to them, you’re not getting the most out of your CGM. Drs. E+P explain how to dose (or not dose) in response to the direction your trend arrows are pointing. Here’s their advice on how to adjust for highs and lows, along with a trend arrow cheat sheet.
read more →
Spartan Races test an athlete’s physical and mental strength with challenging obstacles like leaping over fire and low crawling in mud under barbed wire. Marlon Blanquart has conquered four of these races, all while managing type 1 diabetes.
read more →
A former diabetes educator shares his experience trying fast-acting insulin Lyumjev in his pump, while monitoring mealtime spikes and overall time in range with his Dexcom CGM.
read more →
The FreeStyle Libre 3 was recently approved by the FDA and has many important new features, including continuous blood sugar readings sent directly to your smartphone, better Bluetooth, improved accuracy, and a smaller, slimmer profile.
read more →
The Eversense E3 implantable CGM was recently approved by the FDA and offers a six-month wear time, the longest of any CGM on the market. Drs. E+P explain how the device works, what the implant procedure is like (they’ve both had it done), and what the unique features are of the system.
read more →
Dexcom’s G7 just received CE Mark approval in Europe, with a limited launch expected in the coming weeks. Abbott’s FreeStyle Libre 3 has been available in parts of Europe already, but it is now available for use via the NHS Supply Chain Framework in the UK and under existing eligibility criteria for real-time CGM. Here are the highlights of both systems.
read more →
The long-awaited Eversense E3 implantable CGM has been cleared by the FDA, offering twice the sensor life as the previous version. In addition to its 6-month wear time, it has other features and improvements that make it a unique and appealing CGM option.
read more →
What is an acceptable difference between CGM values and finger stick numbers from a blood glucose meter? Dr. Edelman explains.
read more →
The FDA recently cleared Insulet’s Omnipod 5, the first and only tubeless automated insulin delivery (AID) system in the U.S. with compatible smartphone control and Dexcom G6 CGM integration.
read more →
